MXCT · Company research
MaxCyte, Inc. Common Stock (MXCT): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 1.04 | $123,975,100.92 | 109418100.92 | — | — | — | 12.8458295430525334 | 0.73844811908080483185 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.